Taraxacum fennobalticum Sonck & Y. Mäkinen, n. sp. (sect. Palustria)

Autor: SONCK, C.E.

Publikováno v: Annales Botanici Fennici, 1993 Jan 01. 30(1), 83-85.

Externí odkaz: https://www.jstor.org/stable/23726344

Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas.

Autor: Ahvenainen T; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki.; iCAN Digital Precision Cancer Medicine Flagship., Kaukomaa J; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki., Kämpjärvi K; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki., Uimari O; Department of Obstetrics and Gynecology, Oulu University Hospital.; PEDEGO Research Unit, University of Oulu and Oulu University Hospital.; Medical Research Center Oulu, Oulu University Hospital, University of Oulu., Ahtikoski A; Medical Research Center Oulu, Oulu University Hospital, University of Oulu.; Department of Pathology, Oulu University Hospital.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland., Mäkinen N; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki., Heikinheimo O; Applied Tumor Genomics Research Program.; Department of Obstetrics and Gynecology, Helsinki University Hospital., Aaltonen LA; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki.; iCAN Digital Precision Cancer Medicine Flagship., Karhu A; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki.; iCAN Digital Precision Cancer Medicine Flagship., Bützow R; Applied Tumor Genomics Research Program.; Department of Pathology, Laboratory of Helsinki University Hospital (HUSLAB), Helsinki University Hospital and University of Helsinki, Helsinki., Vahteristo P; Applied Tumor Genomics Research Program.; Department of Medical and Clinical Genetics, University of Helsinki.; iCAN Digital Precision Cancer Medicine Flagship.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2022 Apr 01; Vol. 46 (4), pp. 537-546.

Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.

Autor: Berta DG; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Kuisma H; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Välimäki N; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Räisänen M; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Jäntti M; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Pasanen A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Karhu A; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Kaukomaa J; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Taira A; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Cajuso T; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Nieminen S; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Penttinen RM; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Ahonen S; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Lehtonen R; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Mehine M; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Vahteristo P; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Jalkanen J; Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland., Sahu B; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Ravantti J; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Mäkinen N; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Rajamäki K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Palin K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Taipale J; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Heikinheimo O; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Bützow R; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kaasinen E; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. eevi.kaasinen@helsinki.fi.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. eevi.kaasinen@helsinki.fi., Aaltonen LA; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. lauri.aaltonen@helsinki.fi.; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. lauri.aaltonen@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. lauri.aaltonen@helsinki.fi.

Publikováno v: Nature [Nature] 2021 Aug; Vol. 596 (7872), pp. 398-403. Date of Electronic Publication: 2021 Aug 04.

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.

Autor: Kolterud Å; Department of Biosciences and Nutrition, Karolinska Institutet, 141 83 Huddinge, Sweden., Välimäki N; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Kuisma H; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Patomo J; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Ilves ST; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Mäkinen N; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Kaukomaa J; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Palin K; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland., Kaasinen E; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Karhu A; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland., Pasanen A; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland., Bützow R; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland., Heikinheimo O; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland., Kopp Kallner H; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet,  171 77 Stockholm, Sweden.; Department of Obstetrics and Gynecology, Danderyd Hospital, 182 88 Stockholm, Sweden., Aaltonen LA; Department of Biosciences and Nutrition, Karolinska Institutet, 141 83 Huddinge, Sweden.; Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, 00290 Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.

Publikováno v: Human molecular genetics [Hum Mol Genet] 2023 Mar 20; Vol. 32 (7), pp. 1063-1071.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.